comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 00:57:52 - browse：55341

WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has a far more complicated path to that end than the makers of most medicines or medical devices.

Grail’s controversial blood test Galleri screens for multiple cancers. The Food and Drug Administration has not yet approved it, so Medicare hasn’t had to make a decision on whether to cover it or not. Right now, most people pay for it out of pocket. It runs about $950.

In general, Medicare covers FDA-approved medicines and medical devices that help diagnose or treat disease or injury. But there’s a catch for Grail: Medicare doesn’t cover tests that simply screen healthy people, as Galleri does.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Feng Zhang CRISPR delivery startup lays off quarter of staff

knowledge

WSS

Chronically ill young patients struggle to find fertility info

Head of FDA's diagnostics center, who led through Covid, retires

TikTok, Instagram influencers need more rules for drug ads

UCB departs biotech trade group BIO

Antibiotic resistance and the global rise in human conflict

AdventHealth escalates lawsuit against insurance vendor Multiplan

focus

comprehensive

leisure time

Peter Hotez and the public health issue of online harassment

Federal weight loss drug coverage is 30 years out of date

Apple is now the first public company to be valued at $3 trillion

To bolster infectious disease surveillance, genomics powerhouses team up

Virginia high school admissions case could be legal follow

TikTok, Instagram influencers need more rules for drug ads

Walensky prepares to leave CDC — and Congress — behind

Dana Farber says 6 studies to be retracted and 31 corrected

After affirmative action ruling, medical educators look to 'holistic review'

Why psychiatrists like me stop taking insurance

hotspot

Chronically ill young patients struggle to find fertility info

How a scoliosis diagnosis changed the life of one young dancer

Pumping milk in bathrooms at health conferences is common

Head of FDA's diagnostics center, who led through Covid, retires

The biotech scorecard for Q1: 17 stock

The FDA must approve intranasal treatments for anaphylaxis

focus

focus

knowledge

leisure time